Skip to main content
. 2024 Jul 30;115(10):3394–3402. doi: 10.1111/cas.16297

FIGURE 2.

FIGURE 2

Response to temozolomide‐containing chemotherapy in patients with osteosarcoma who experienced recurrence or progression, grouped by O‐6‐methylguanine‐DNA methyltransferase (MGMT) protein expression. CR, complete response; int/high, intermediate/high expression; no/low, no/low expression; PD, progressive disease; PR, partial response; SD, stable disease.